Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica A Lavery

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Cancer|September 22, 2024
Effects of exercise therapy on chemotherapy delivery and response in primary breast cancer: A secondary analysis of a randomized trialNeil M Iyengar, Jessica M Scott, Jasme Lee, et al.
JCO Precision Oncology|March 14, 2024
Biomarker Inference and the Timing of Next-Generation Sequencing in a Multi-Institutional, Cross-Cancer Clinicogenomic Data SetKenneth L Kehl, Jessica A Lavery, Samantha Brown, et al.
JAMA Network Open|July 26, 2021
Correlation Between Surrogate End Points and Overall Survival in a Multi-institutional Clinicogenomic Cohort of Patients With Non-Small Cell Lung or Colorectal CancerKenneth L Kehl, Gregory J Riely, Eva M Lepisto, et al.
Gynecologic Oncology|July 16, 2023
Leave it in the past - primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary studyTiffany Y Sia, Beryl L Manning-Geist, Sarah Ehmann, et al.
JCO Clinical Cancer Informatics|August 7, 2020
Linked Entity Attribute Pair (LEAP): A Harmonization Framework for Data PoolingStacy Thomas, Tara Lichtenberg, Kristen Dang, et al.
Gynecologic Oncology|August 21, 2020
Impact of provider volume on front-line chemotherapy guideline compliance and overall survival in elderly patients with advanced ovarian cancerEmeline M Aviki, Jessica A Lavery, Kara Long Roche, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 4, 2022
Impact of Exercise on Susceptibility and Severity of COVID-19 in Patients with Cancer: A Retrospective StudyJoshua W Bliss, Jessica A Lavery, Whitney P Underwood, et al.
JCO Clinical Cancer Informatics|February 22, 2022
A Scalable Quality Assurance Process for Curating Oncology Electronic Health Records: The Project GENIE Biopharma Collaborative ApproachJessica A Lavery, Eva M Lepisto, Samantha Brown, et al.
JAMA Oncology|November 4, 2021
Implications of Selection Bias Due to Delayed Study Entry in Clinical Genomic StudiesSamantha Brown, Jessica A Lavery, Ronglai Shen, et al.
Annals of Surgical Oncology|March 25, 2023
MRI Assessment of Extramural Venous Invasion Before and After Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer and Its Association with Disease-Free and Overall SurvivalHannah M Thompson, David D B Bates, Jennifer Golia Pernicka, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Cancer|September 22, 2024
Effects of exercise therapy on chemotherapy delivery and response in primary breast cancer: A secondary analysis of a randomized trialNeil M Iyengar, Jessica M Scott, Jasme Lee, et al.
JCO Precision Oncology|March 14, 2024
Biomarker Inference and the Timing of Next-Generation Sequencing in a Multi-Institutional, Cross-Cancer Clinicogenomic Data SetKenneth L Kehl, Jessica A Lavery, Samantha Brown, et al.
JAMA Network Open|July 26, 2021
Correlation Between Surrogate End Points and Overall Survival in a Multi-institutional Clinicogenomic Cohort of Patients With Non-Small Cell Lung or Colorectal CancerKenneth L Kehl, Gregory J Riely, Eva M Lepisto, et al.
Gynecologic Oncology|July 16, 2023
Leave it in the past - primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary studyTiffany Y Sia, Beryl L Manning-Geist, Sarah Ehmann, et al.
JCO Clinical Cancer Informatics|August 7, 2020
Linked Entity Attribute Pair (LEAP): A Harmonization Framework for Data PoolingStacy Thomas, Tara Lichtenberg, Kristen Dang, et al.
Gynecologic Oncology|August 21, 2020
Impact of provider volume on front-line chemotherapy guideline compliance and overall survival in elderly patients with advanced ovarian cancerEmeline M Aviki, Jessica A Lavery, Kara Long Roche, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 4, 2022
Impact of Exercise on Susceptibility and Severity of COVID-19 in Patients with Cancer: A Retrospective StudyJoshua W Bliss, Jessica A Lavery, Whitney P Underwood, et al.
JCO Clinical Cancer Informatics|February 22, 2022
A Scalable Quality Assurance Process for Curating Oncology Electronic Health Records: The Project GENIE Biopharma Collaborative ApproachJessica A Lavery, Eva M Lepisto, Samantha Brown, et al.
JAMA Oncology|November 4, 2021
Implications of Selection Bias Due to Delayed Study Entry in Clinical Genomic StudiesSamantha Brown, Jessica A Lavery, Ronglai Shen, et al.
Annals of Surgical Oncology|March 25, 2023
MRI Assessment of Extramural Venous Invasion Before and After Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer and Its Association with Disease-Free and Overall SurvivalHannah M Thompson, David D B Bates, Jennifer Golia Pernicka, et al.
Pageof 8